Evidence map›Paper›PMID 41136438›Full record

ArticleScientific reports2025

Association of early cardiac rehabilitation on mortality in patients with dilated cardiomyopathy using national inpatient database.

Yuichi Yasufuku, Yuichi Nishioka, Hideo Yasunaga, Tomoaki Imamura

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuichi YasufukuDepartment of Biostatistics and Data Science, Graduate School of Medicine, The University of Osaka, Suita, Japan. yyasufuku.bsds@osaka-u.ac.jp.
Yuichi NishiokaDepartment of Public Health, Health Management and Policy, Nara Medical University, Kashihara, Japan.
Hideo YasunagaDepartment of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Tomoaki ImamuraDepartment of Public Health, Health Management and Policy, Nara Medical University, Kashihara, Japan.

Funding

Ministry of Health, Labour and Welfare 23AA2003
6 · The paper itself

Abstract

Dilated cardiomyopathy (DCM) is a complex disease characterized by cardiomyopathic hypokinesis and left ventricular interior hypertrophy. Cardiac rehabilitation (CR) is an established treatment for some cardiovascular diseases; however, the outcomes of early CR for patients with DCM remain underexplored. This study aimed to investigate the association between early CR and 90-day mortality in patients with DCM and symptomatic heart failure, using a national inpatient database in Japan from July 1, 2010, to March 31, 2020. We applied multiple imputation to the missing data and propensity score matching analysis. Early CR was defined as that initiated within 3 days of admission. The study included 30,296 eligible patients, including those with early CR (n = 3,130) and delayed or no CR (n = 27,166). The early CR group showed significantly lower 90-day mortality compared to the delayed or no CR group (odds ratio, 0.70, 95% confidence interval, 0.53-0.93; P = 0.01). Compared to the delayed or no CR group, the early CR group exhibited a higher activities of daily living score at discharge, but there was no significant difference in length of stay between the groups.

Indexed as

Cardiac RehabilitationCardiomyopathy, DilatedActivities of Daily LivingAgedDatabases, FactualFemaleHumansInpatientsJapanLength of StayMaleMiddle AgedPropensity ScoreAcute heart failureCardiac rehabilitationDilated cardiomyopathyPropensity score

Identifiers

PMID41136438
PMCPMC12552675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.